Putnam Investments LLC Ligand Pharmaceuticals Inc Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Putnam Investments LLC holds 5,503 shares of LGND stock, worth $667,238. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,503

Previous 5,647 2.55%

Holding current value

$667,238

Previous $338,000 16.27%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $7,138 - $10,458	-144 Reduced 2.55%	5,503 $393,000
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $332,382 - $410,367	5,647 New	5,647 $338,000
Q4 2020 Feb 16, 2021	SELL	$80.55 - $106.05 $2.03 Million - $2.68 Million	-25,225 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $2.27 Million - $3.21 Million	-25,367 Reduced 50.14%	25,225 $2.4 Million
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $1.79 Million - $3.25 Million	26,263 Added 107.95%	50,592 $5.66 Million
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $833,568 - $1.42 Million	-13,154 Reduced 35.09%	24,329 $1.77 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $222,697 - $310,253	-2,582 Reduced 6.44%	37,483 $3.73 Million
Q1 2019 May 15, 2019	SELL	$105.93 - $142.47 $924,027 - $1.24 Million	-8,723 Reduced 17.88%	40,065 $5.04 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $6.06 Million - $7.88 Million	28,699 Added 142.86%	48,788 $13.4 Million
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $781,440 - $1.08 Million	-5,183 Reduced 20.51%	20,089 $4.16 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $782,566 - $1.03 Million	5,645 Added 28.76%	25,272 $4.17 Million
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $18,612 - $21,320	-145 Reduced 0.73%	19,627 $2.69 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $2.39 Million - $2.73 Million	19,772	19,772 $2.69 Million

Others Institutions Holding LGND

# of Institutions

248

Shares Held

17.7M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.05B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Ligand Pharmaceuticals Inc Transaction History